Continuous glucose monitoring guided insulin therapy is associated with improved clinical outcomes in cystic fibrosis-related diabetes
Journal of Cystic Fibrosis Jun 14, 2018
Frost F, et al. - Researchers determined the impact of continuous glucose monitoring (CGM) guided insulin initiation on the outcomes (including weight and pulmonary function changes over the next 12 months) in adults without a prior diagnosis of cystic fibrosis related diabetes (CFRD) presented at their centre. They analyzed CGM profiles for 59 patients and started insulin therapy in 37 patients who had evidence of hyperglycaemia on CGM. Findings demonstrated that improvements in lung function (improved forced expiratory volume in 1 s) and weight with subsequent reduced pulmonary function decline was observed in association with insulin treatment targeted towards glycaemic excursions seen on CGM.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries